Related Experiment Video
Updated: Aug 22, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death
N Lowri Thomas1, Christopher H George, F Anthony Lai
1Department of Cardiology, Wales Heart Research Institute, University of Wales College of Medicine, Heath Park, Cardiff, Wales CF14 4XN, UK.
Objectives:
Point mutations in the cardiac ryanodine receptor (RyR2) mediate abnormal intracellular Ca(2+) release and are associated with stress-induced ventricular tachycardia (VT), leading to sudden cardiac death (SCD). Although the precise molecular basis of RyR2 dysfunction in SCD remains controversial, there is consensus that the mutations characterised to date all exhibit gain-of-function Ca(2+) release properties following cell stimulation. We investigated the functional impact of a distinct set of SCD-linked RyR2 mutations (L(433)P, N(2386)I, R(176)Q/T(2504)M) on intracellular Ca(2+) handling.
Methods:
We expressed full-length recombinant human wild-type (WT) and SCD-linked RyR2 mutations in human embryonic kidney (HEK) cells, and profiled the spatial and amplitude characteristics of caffeine-evoked Ca(2+) release through homo-tetrameric channels in living cells using rapid confocal laser scanning microscopy.
Results:
Analysis of the precise mode of Ca(2+) release in HEK cells expressing RyR2 mutants demonstrated profound differences when compared with WT channels. The SCD-linked RyR2 mutations characterised in this study exhibited heterogeneous Ca(2+) release profiles, including the novel observation that one of the mutants, (L(433)P), exhibited a marked reduction in sensitivity to channel activation. However, all SCD-linked RyR2 mutations characterised in this study resulted in an increased duration of elevated cytoplasmic Ca(2+) levels following channel activation.
Conclusions:
Our live cell-based data demonstrates functional heterogeneity of Ca(2+) release through SCD-linked RyR2 mutants, suggesting that the mechanistic basis of RyR2 dysfunction in SCD may be more complex than previously anticipated. These findings may have profound consequences for the therapeutic modulation of RyR2 in stress-induced VT and SCD.
Insights
Mutations in cardiac ryanodine receptor (RyR2) linked to sudden cardiac death (SCD) show varied effects on calcium release. Some RyR2 mutations increase calcium levels, potentially complicating therapies for stress-induced ventricular tachycardia (VT).
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genetics
Background:
- Point mutations in the cardiac ryanodine receptor (RyR2) are linked to abnormal intracellular calcium (Ca2+) release.
- These RyR2 mutations are associated with stress-induced ventricular tachycardia (VT) and sudden cardiac death (SCD).
- The exact molecular mechanisms of RyR2 dysfunction in SCD are debated, but mutations are thought to increase Ca2+ release.
Purpose of the Study:
- To investigate the functional impact of specific SCD-linked RyR2 mutations (L433P, N2386I, R176Q/T2504M) on intracellular Ca2+ handling.
- To characterize the Ca2+ release properties of these RyR2 mutants in a cellular model.
Main Methods:
- Full-length recombinant human wild-type (WT) and SCD-linked RyR2 mutations were expressed in human embryonic kidney (HEK) cells.
- Caffeine-evoked Ca2+ release through homo-tetrameric channels was profiled in living cells using rapid confocal laser scanning microscopy.
Main Results:
- SCD-linked RyR2 mutations displayed heterogeneous Ca2+ release profiles compared to WT channels.
- One mutant, L433P, showed a reduced sensitivity to channel activation.
- All characterized SCD-linked RyR2 mutations resulted in a prolonged elevation of cytoplasmic Ca2+ levels after channel activation.
Conclusions:
- Live cell data reveal functional heterogeneity in Ca2+ release through SCD-linked RyR2 mutants.
- The underlying mechanisms of RyR2 dysfunction in SCD may be more complex than previously assumed.
- Findings could impact therapeutic strategies for stress-induced VT and SCD targeting RyR2.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Cardiomyopathy IV: Restrictive Cardiomyopathy
